Skip to main content

Animations

MJFF Publications

5391 - 5400 of 9030 Results
Title
Year
  • Year
  • 2024
  • 2023
  • 2022
  • 2023
  • 2023
  • 2023
  • 2022
  • 2020
  • 2021
  • 2022
  • Summary Details
    OPEN
    Title: Determination of optimal vibration dose to treat Parkinson's disease gait symptoms: A clinical trial
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2024.100248
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Developing better digital health measures of Parkinson’s disease using free living data and a crowdsourced data analysis challenge
    Journal Name: PLOS Digital Health
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pdig.0000208
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Protracted course progressive supranuclear palsy
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/ene.15346
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Striatal serotonin transporter gain-of-function in L-DOPA-treated, hemi-parkinsonian rats
    Journal Name: Brain Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.brainres.2023.148381
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Human upper extremity motor cortex activity shows distinct oscillatory signatures for stereotyped arm and leg movements
    Journal Name: Frontiers in Human Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnhum.2023.1212963
    Citation Count: 6
  • Summary Details
    OPEN
    Title: A beginner’s guide into curated analyses of open access datasets for biomarker discovery in neurodegeneration
    Journal Name: Scientific Data
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41597-023-02338-1
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Plasma MIA , CRP , and Albumin Predict Cognitive Decline in Parkinson's Disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.26410
    Citation Count: 32
  • Summary Details
    OPEN
    Title: Mutated ATP10B increases Parkinson’s disease risk by compromising lysosomal glucosylceramide export
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-020-02145-7
    Citation Count: 65
  • Summary Details
    OPEN
    Title: Predicting optimal deep brain stimulation parameters for Parkinson’s disease using functional MRI and machine learning
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-021-23311-9
    Citation Count: 296
  • Summary Details
    OPEN
    Title: Nanobodies as allosteric modulators of Parkinson’s disease–associated LRRK2
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.2112712119
    Citation Count: 55
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.